Background Most of the world's sickle cell disease (SCD) burden is in Africa, where it is a
major contributor to child morbidity and mortality. Despite the low cost of many preventive …

Abstract Background In Africa, health practitioners and the current knowledge of the public
on genetics and genomics is still very low and yet this has potential to reduce the burden of …

Out-of-pocket spending and lack of adequate health policy support for people living with
sickle cell disease in Nigeria may predispose to high economic burden and catastrophic …

Sickle cell disease (SCD) is the most common clinically significant hemoglobinopathy,
characterized by painful episodes, anemia, high risk of infection, and other acute and …

Background Sickle cell disease (SCD) may cause several impacts to patients and the whole
society. About 4% of the population has the sickle cell trait in Brazil, and 60,000 to 100,000 …

Background Interest in the financial burden of informal caregivers has been growing.
Unfortunately, it remains unclear which method (s) should be used when quantifying this …

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of
sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits …

Abstract Background and Aims Sickle cell disease (SCD) is the commonest monogenic
haemolytic disorder in Africa. Despite strides made in its management, a significant …

Sickle cell disease (SCD) is a genetic disorder with an estimated 5200 live births each year
indicating towards a major public health issue in India. Although SCD has been described in …

Objective: To identify and characterize hospital admissions and readmissions in the
Brazilian Unified Public Health System (Sistema Único de Saúde [SUS]) in children with …